MindRank AI (德睿智药)
Hang Zhou Shi, China
MindRank AI (德睿智药) focuses on the research and development of new AI drugs, and has a one-stop AI-driven drug discovery platform-the medical knowledge graph PharmKG™️ and the drug design platform Molecule Pro™️. In 2018, the De Rui Zhi Pharmaceutical team has begun technical research and development, perfecting and verifying the capabilities of the self-developed artificial intelligence pharmaceutical platform. The team returned to China in November 2020 and established De Rui Zhiyao in Hangzhou, hoping to bring the mature one-stop AI drug research and development technology and development model back to China, and quickly start the commercialization cooperation and pipeline development of the platform.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2020
- Website
- www.mindrank.ai/en
Categories
Disease Areas
Technologies
Only accessible to MedStartr community members.
Join nowWhat do you think of MindRank AI (德睿智药)?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now